EMEA (Europe, Middle East and Africa) Active Pharmaceutical Ingredients Market Report 2018

March 2018 | 129 pages | ID: E22590FA24CEN
QYResearch

Abstracts

In this report, the EMEA Active Pharmaceutical Ingredients market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Active Pharmaceutical Ingredients for these regions, from 2013 to 2025 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Active Pharmaceutical Ingredients market competition by top manufacturers/players, with Active Pharmaceutical Ingredients sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Teva
• Mylan
• DSM
• Aurobindo Pharma
• Aspen
• Novartis
• BASF
• Pfizer
• Huahai Pharmaceutical
• Hisun Pharmaceutical
• Sun Pharmaceutical Industries
• Zhejiang Medicine
• Dr. Reddy's Laboratories
• Zhejiang NHU
• Bayer
• NCPC
• AbbVie
• Shandong Xinhua Pharmaceutical
• Northeast Pharm
• Harbin Pharmaceutical
• LKPC

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Synthetic APIs
• Biotech APIs

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• CNS
• Cardiovascular
• Genitourinary/Hormonal Drugs
• Respiratory
• Rheumatology
• Diabetes
• Oncology
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Active Pharmaceutical Ingredients Market Report 2018

1 ACTIVE PHARMACEUTICAL INGREDIENTS OVERVIEW

1.1 Product Overview and Scope of Active Pharmaceutical Ingredients
1.2 Classification of Active Pharmaceutical Ingredients
  1.2.1 EMEA Active Pharmaceutical Ingredients Market Size (Sales) Comparison by Type (2013-2025)
  1.2.2 EMEA Active Pharmaceutical Ingredients Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 Synthetic APIs
  1.2.4 Biotech APIs
1.3 EMEA Active Pharmaceutical Ingredients Market by Application/End Users
  1.3.1 EMEA Active Pharmaceutical Ingredients Sales (Volume) and Market Share Comparison by Application (2013-2025)
  1.3.2 CNS
  1.3.3 Cardiovascular
  1.3.4 Genitourinary/Hormonal Drugs
  1.3.5 Respiratory
  1.3.6 Rheumatology
  1.3.7 Diabetes
  1.3.8 Oncology
  1.3.9 Others
1.4 EMEA Active Pharmaceutical Ingredients Market by Region
  1.4.1 EMEA Active Pharmaceutical Ingredients Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 Europe Status and Prospect (2013-2025)
  1.4.3 Middle East Status and Prospect (2013-2025)
  1.4.4 Africa Status and Prospect (2013-2025)
1.5 EMEA Market Size (Value and Volume) of Active Pharmaceutical Ingredients (2013-2025)
  1.5.1 EMEA Active Pharmaceutical Ingredients Sales and Growth Rate (2013-2025)
  1.5.2 EMEA Active Pharmaceutical Ingredients Revenue and Growth Rate (2013-2025)

2 EMEA ACTIVE PHARMACEUTICAL INGREDIENTS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Active Pharmaceutical Ingredients Market Competition by Players/Manufacturers
  2.1.1 EMEA Active Pharmaceutical Ingredients Sales Volume and Market Share of Major Players (2013-2018)
  2.1.2 EMEA Active Pharmaceutical Ingredients Revenue and Share by Players (2013-2018)
  2.1.3 EMEA Active Pharmaceutical Ingredients Sale Price by Players (2013-2018)
2.2 EMEA Active Pharmaceutical Ingredients (Volume and Value) by Type/Product Category
  2.2.1 EMEA Active Pharmaceutical Ingredients Sales and Market Share by Type (2013-2018)
  2.2.2 EMEA Active Pharmaceutical Ingredients Revenue and Market Share by Type (2013-2018)
  2.2.3 EMEA Active Pharmaceutical Ingredients Sale Price by Type (2013-2018)
2.3 EMEA Active Pharmaceutical Ingredients (Volume) by Application
2.4 EMEA Active Pharmaceutical Ingredients (Volume and Value) by Region
  2.4.1 EMEA Active Pharmaceutical Ingredients Sales and Market Share by Region (2013-2018)
  2.4.2 EMEA Active Pharmaceutical Ingredients Revenue and Market Share by Region (2013-2018)
  2.4.3 EMEA Active Pharmaceutical Ingredients Sales Price by Region (2013-2018)

3 EUROPE ACTIVE PHARMACEUTICAL INGREDIENTS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Active Pharmaceutical Ingredients Sales and Value (2013-2018)
  3.1.1 Europe Active Pharmaceutical Ingredients Sales Volume and Growth Rate (2013-2018)
  3.1.2 Europe Active Pharmaceutical Ingredients Revenue and Growth Rate (2013-2018)
3.2 Europe Active Pharmaceutical Ingredients Sales and Market Share by Type
3.3 Europe Active Pharmaceutical Ingredients Sales and Market Share by Application
3.4 Europe Active Pharmaceutical Ingredients Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Active Pharmaceutical Ingredients Sales Volume by Countries (2013-2018)
  3.4.2 Europe Active Pharmaceutical Ingredients Revenue by Countries (2013-2018)
  3.4.3 Germany Active Pharmaceutical Ingredients Sales and Growth Rate (2013-2018)
  3.4.4 France Active Pharmaceutical Ingredients Sales and Growth Rate (2013-2018)
  3.4.5 UK Active Pharmaceutical Ingredients Sales and Growth Rate (2013-2018)
  3.4.6 Russia Active Pharmaceutical Ingredients Sales and Growth Rate (2013-2018)
  3.4.7 Italy Active Pharmaceutical Ingredients Sales and Growth Rate (2013-2018)
  3.4.8 Benelux Active Pharmaceutical Ingredients Sales and Growth Rate (2013-2018)

4 MIDDLE EAST ACTIVE PHARMACEUTICAL INGREDIENTS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Active Pharmaceutical Ingredients Sales and Value (2013-2018)
  4.1.1 Middle East Active Pharmaceutical Ingredients Sales Volume and Growth Rate (2013-2018)
  4.1.2 Middle East Active Pharmaceutical Ingredients Revenue and Growth Rate (2013-2018)
4.2 Middle East Active Pharmaceutical Ingredients Sales and Market Share by Type
4.3 Middle East Active Pharmaceutical Ingredients Sales and Market Share by Application
4.4 Middle East Active Pharmaceutical Ingredients Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Active Pharmaceutical Ingredients Sales Volume by Countries (2013-2018)
  4.4.2 Middle East Active Pharmaceutical Ingredients Revenue by Countries (2013-2018)
  4.4.3 Saudi Arabia Active Pharmaceutical Ingredients Sales and Growth Rate (2013-2018)
  4.4.4 Israel Active Pharmaceutical Ingredients Sales and Growth Rate (2013-2018)
  4.4.5 UAE Active Pharmaceutical Ingredients Sales and Growth Rate (2013-2018)
  4.4.6 Iran Active Pharmaceutical Ingredients Sales and Growth Rate (2013-2018)

5 AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Active Pharmaceutical Ingredients Sales and Value (2013-2018)
  5.1.1 Africa Active Pharmaceutical Ingredients Sales Volume and Growth Rate (2013-2018)
  5.1.2 Africa Active Pharmaceutical Ingredients Revenue and Growth Rate (2013-2018)
5.2 Africa Active Pharmaceutical Ingredients Sales and Market Share by Type
5.3 Africa Active Pharmaceutical Ingredients Sales and Market Share by Application
5.4 Africa Active Pharmaceutical Ingredients Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Active Pharmaceutical Ingredients Sales Volume by Countries (2013-2018)
  5.4.2 Africa Active Pharmaceutical Ingredients Revenue by Countries (2013-2018)
  5.4.3 South Africa Active Pharmaceutical Ingredients Sales and Growth Rate (2013-2018)
  5.4.4 Nigeria Active Pharmaceutical Ingredients Sales and Growth Rate (2013-2018)
  5.4.5 Egypt Active Pharmaceutical Ingredients Sales and Growth Rate (2013-2018)
  5.4.6 Algeria Active Pharmaceutical Ingredients Sales and Growth Rate (2013-2018)

6 EMEA ACTIVE PHARMACEUTICAL INGREDIENTS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Teva
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Teva Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Mylan
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Mylan Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 DSM
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 DSM Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Aurobindo Pharma
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Aurobindo Pharma Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Aspen
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Aspen Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Novartis
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Novartis Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 BASF
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 BASF Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Pfizer
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Pfizer Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Huahai Pharmaceutical
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Huahai Pharmaceutical Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Hisun Pharmaceutical
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Active Pharmaceutical Ingredients Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Hisun Pharmaceutical Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 Sun Pharmaceutical Industries
6.12 Zhejiang Medicine
6.13 Dr. Reddy's Laboratories
6.14 Zhejiang NHU
6.15 Bayer
6.16 NCPC
6.17 AbbVie
6.18 Shandong Xinhua Pharmaceutical
6.19 Northeast Pharm
6.20 Harbin Pharmaceutical
6.21 LKPC

7 ACTIVE PHARMACEUTICAL INGREDIENTS MANUFACTURING COST ANALYSIS

7.1 Active Pharmaceutical Ingredients Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Active Pharmaceutical Ingredients

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Active Pharmaceutical Ingredients Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Active Pharmaceutical Ingredients Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FORECAST (2018-2025)

11.1 EMEA Active Pharmaceutical Ingredients Sales, Revenue and Price Forecast (2018-2025)
  11.1.1 EMEA Active Pharmaceutical Ingredients Sales and Growth Rate Forecast (2018-2025)
  11.1.2 EMEA Active Pharmaceutical Ingredients Revenue and Growth Rate Forecast (2018-2025)
  11.1.3 EMEA Active Pharmaceutical Ingredients Price and Trend Forecast (2018-2025)
11.2 EMEA Active Pharmaceutical Ingredients Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.3 Europe Active Pharmaceutical Ingredients Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.4 Middle Eastt Active Pharmaceutical Ingredients Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.5 Africa Active Pharmaceutical Ingredients Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.6 EMEA Active Pharmaceutical Ingredients Sales Forecast by Type (2018-2025)
11.7 EMEA Active Pharmaceutical Ingredients Sales Forecast by Application (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Active Pharmaceutical Ingredients
Figure EMEA Active Pharmaceutical Ingredients Sales Volume (K Units) by Type (2013-2025)
Figure EMEA Active Pharmaceutical Ingredients Sales Volume Market Share by Type (Product Category) in 2017
Figure Synthetic APIs Product Picture
Figure Biotech APIs Product Picture
Figure EMEA Active Pharmaceutical Ingredients Sales Volume (K Units) by Application (2013-2025)
Figure EMEA Sales Market Share of Active Pharmaceutical Ingredients by Application in 2017
Figure CNS Examples
Table Key Downstream Customer in CNS
Figure Cardiovascular Examples
Table Key Downstream Customer in Cardiovascular
Figure Genitourinary/Hormonal Drugs Examples
Table Key Downstream Customer in Genitourinary/Hormonal Drugs
Figure Respiratory Examples
Table Key Downstream Customer in Respiratory
Figure Rheumatology Examples
Table Key Downstream Customer in Rheumatology
Figure Diabetes Examples
Table Key Downstream Customer in Diabetes
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Active Pharmaceutical Ingredients Market Size (Million USD) by Region (2013-2025)
Figure Europe Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Active Pharmaceutical Ingredients Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate (2013-2025)
Figure Middle East Active Pharmaceutical Ingredients Revenue (Million USD) Status and Forecast by Countries
Figure Africa Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate (2013-2025)
Figure Africa Active Pharmaceutical Ingredients Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Active Pharmaceutical Ingredients Sales Volume and Growth Rate (2013-2025)
Figure EMEA Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate (2013-2025)
Figure EMEA Active Pharmaceutical Ingredients Market Major Players Product Sales Volume (K Units) (2013-2018)
Table EMEA Active Pharmaceutical Ingredients Sales Volume (K Units) of Major Players (2013-2018)
Table EMEA Active Pharmaceutical Ingredients Sales Share by Players (2013-2018)
Figure 2017 Active Pharmaceutical Ingredients Sales Share by Players
Figure 2017 Active Pharmaceutical Ingredients Sales Share by Players
Figure EMEA Active Pharmaceutical Ingredients Market Major Players Product Revenue (Million USD) (2013-2018)
Table EMEA Active Pharmaceutical Ingredients Revenue (Million USD) by Players (2013-2018)
Table EMEA Active Pharmaceutical Ingredients Revenue Share by Players (2013-2018)
Table 2017 EMEA Active Pharmaceutical Ingredients Revenue Share by Players
Table 2017 EMEA Active Pharmaceutical Ingredients Revenue Share by Players
Table EMEA Active Pharmaceutical Ingredients Sale Price (USD/Unit) by Players (2013-2018)
Table EMEA Active Pharmaceutical Ingredients Sales (K Units) and Market Share by Type (2013-2018)
Table EMEA Active Pharmaceutical Ingredients Sales Share by Type (2013-2018)
Figure Sales Market Share of Active Pharmaceutical Ingredients by Type (2013-2018)
Figure EMEA Active Pharmaceutical Ingredients Sales Market Share by Type (2013-2018)
Table EMEA Active Pharmaceutical Ingredients Revenue (Million USD) and Market Share by Type (2013-2018)
Table EMEA Active Pharmaceutical Ingredients Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Active Pharmaceutical Ingredients by Type in 2017
Table EMEA Active Pharmaceutical Ingredients Sale Price (USD/Unit) by Type (2013-2018)
Table EMEA Active Pharmaceutical Ingredients Sales (K Units) and Market Share by Application (2013-2018)
Table EMEA Active Pharmaceutical Ingredients Sales Share by Application (2013-2018)
Figure Sales Market Share of Active Pharmaceutical Ingredients by Application (2013-2018)
Figure EMEA Active Pharmaceutical Ingredients Sales Market Share by Application in 2017
Table EMEA Active Pharmaceutical Ingredients Sales (K Units) and Market Share by Region (2013-2018)
Table EMEA Active Pharmaceutical Ingredients Sales Share by Region (2013-2018)
Figure Sales Market Share of Active Pharmaceutical Ingredients by Region (2013-2018)
Figure EMEA Active Pharmaceutical Ingredients Sales Market Share in 2017
Table EMEA Active Pharmaceutical Ingredients Revenue (Million USD) and Market Share by Region (2013-2018)
Table EMEA Active Pharmaceutical Ingredients Revenue Share by Region (2013-2018)
Figure Revenue Market Share of Active Pharmaceutical Ingredients by Region (2013-2018)
Figure EMEA Active Pharmaceutical Ingredients Revenue Market Share Regions in 2017
Table EMEA Active Pharmaceutical Ingredients Sales Price (USD/Unit) by Region (2013-2018)
Figure Europe Active Pharmaceutical Ingredients Sales (K Units) and Growth Rate (2013-2018)
Figure Europe Active Pharmaceutical Ingredients Revenue and Growth Rate (2013-2018)
Table Europe Active Pharmaceutical Ingredients Sales (K Units) by Type (2013-2018)
Table Europe Active Pharmaceutical Ingredients Market Share by Type (2013-2018)
Figure Europe Active Pharmaceutical Ingredients Market Share by Type in 2017
Table Europe Active Pharmaceutical Ingredients Sales (K Units) by Application (2013-2018)
Table Europe Active Pharmaceutical Ingredients Market Share by Application (2013-2018)
Figure Europe Active Pharmaceutical Ingredients Market Share by Application in 2017
Table Europe Active Pharmaceutical Ingredients Sales (K Units) by Countries (2013-2018)
Table Europe Active Pharmaceutical Ingredients Sales Market Share by Countries (2013-2018)
Figure Europe Active Pharmaceutical Ingredients Sales Market Share by Countries (2013-2018)
Figure Europe Active Pharmaceutical Ingredients Sales Market Share by Countries in 2017
Table Europe Active Pharmaceutical Ingredients Revenue (Million USD) by Countries (2013-2018)
Table Europe Active Pharmaceutical Ingredients Revenue Market Share by Countries (2013-2018)
Figure Europe Active Pharmaceutical Ingredients Revenue Market Share by Countries (2013-2018)
Figure Europe Active Pharmaceutical Ingredients Revenue Market Share by Countries in 2017
Figure Germany Active Pharmaceutical Ingredients Sales (K Units) and Growth Rate (2013-2018)
Figure France Active Pharmaceutical Ingredients Sales (K Units) and Growth Rate (2013-2018)
Figure UK Active Pharmaceutical Ingredients Sales (K Units) and Growth Rate (2013-2018)
Figure Russia Active Pharmaceutical Ingredients Sales (K Units) and Growth Rate (2013-2018)
Figure Italy Active Pharmaceutical Ingredients Sales (K Units) and Growth Rate (2013-2018)
Figure Benelux Active Pharmaceutical Ingredients Sales (K Units) and Growth Rate (2013-2018)
Figure Middle East Active Pharmaceutical Ingredients Sales (K Units) and Growth Rate (2013-2018)
Figure Middle East Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate (2013-2018)
Table Middle East Active Pharmaceutical Ingredients Sales (K Units) by Type (2013-2018)
Table Middle East Active Pharmaceutical Ingredients Market Share by Type (2013-2018)
Figure Middle East Active Pharmaceutical Ingredients Market Share by Type (2013-2018)
Table Middle East Active Pharmaceutical Ingredients Sales (K Units) by Applications (2013-2018)
Table Middle East Active Pharmaceutical Ingredients Market Share by Applications (2013-2018)
Figure Middle East Active Pharmaceutical Ingredients Sales Market Share by Application in 2017
Table Middle East Active Pharmaceutical Ingredients Sales Volume (K Units) by Countries (2013-2018)
Table Middle East Active Pharmaceutical Ingredients Sales Volume Market Share by Countries (2013-2018)
Figure Middle East Active Pharmaceutical Ingredients Sales Volume Market Share by Countries in 2017
Table Middle East Active Pharmaceutical Ingredients Revenue (Million USD) by Countries (2013-2018)
Table Middle East Active Pharmaceutical Ingredients Revenue Market Share by Countries (2013-2018)
Figure Middle East Active Pharmaceutical Ingredients Revenue Market Share by Countries (2013-2018)
Figure Middle East Active Pharmaceutical Ingredients Revenue Market Share by Countries in 2017
Figure Saudi Arabia Active Pharmaceutical Ingredients Sales (K Units) and Growth Rate (2013-2018)
Figure Israel Active Pharmaceutical Ingredients Sales (K Units) and Growth Rate (2013-2018)
Figure UAE Active Pharmaceutical Ingredients Sales (K Units) and Growth Rate (2013-2018)
Figure Iran Active Pharmaceutical Ingredients Sales (K Units) and Growth Rate (2013-2018)
Figure Africa Active Pharmaceutical Ingredients Sales (K Units) and Growth Rate (2013-2018)
Figure Africa Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate (2013-2018)
Table Africa Active Pharmaceutical Ingredients Sales (K Units) by Type (2013-2018)
Table Africa Active Pharmaceutical Ingredients Sales Market Share by Type (2013-2018)
Figure Africa Active Pharmaceutical Ingredients Sales Market Share by Type (2013-2018)
Figure Africa Active Pharmaceutical Ingredients Sales Market Share by Type in 2017
Table Africa Active Pharmaceutical Ingredients Sales (K Units) by Application (2013-2018)
Table Africa Active Pharmaceutical Ingredients Sales Market Share by Application (2013-2018)
Figure Africa Active Pharmaceutical Ingredients Sales Market Share by Application (2013-2018)
Table Africa Active Pharmaceutical Ingredients Sales Volume (K Units) by Countries (2013-2018)
Table Africa Active Pharmaceutical Ingredients Sales Market Share by Countries (2013-2018)
Figure Africa Active Pharmaceutical Ingredients Sales Market Share by Countries (2013-2018)
Figure Africa Active Pharmaceutical Ingredients Sales Market Share by Countries in 2017
Table Africa Active Pharmaceutical Ingredients Revenue (Million USD) by Countries (2013-2018)
Table Africa Active Pharmaceutical Ingredients Revenue Market Share by Countries (2013-2018)
Figure Africa Active Pharmaceutical Ingredients Revenue Market Share by Countries (2013-2018)
Figure Africa Active Pharmaceutical Ingredients Revenue Market Share by Countries in 2017
Figure South Africa Active Pharmaceutical Ingredients Sales (K Units) and Growth Rate (2013-2018)
Figure Nigeria Active Pharmaceutical Ingredients Sales (K Units) and Growth Rate (2013-2018)
Figure Egypt Active Pharmaceutical Ingredients Sales (K Units) and Growth Rate (2013-2018)
Figure Algeria Active Pharmaceutical Ingredients Sales (K Units) and Growth Rate (2013-2018)
Table Teva Active Pharmaceutical Ingredients Basic Information List
Table Teva Active Pharmaceutical Ingredients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Teva Active Pharmaceutical Ingredients Sales (K Units) and Growth Rate (2013-2018)
Figure Teva Active Pharmaceutical Ingredients Sales Market Share in EMEA (2013-2018)
Figure Teva Active Pharmaceutical Ingredients Revenue Market Share in EMEA (2013-2018)
Table Mylan Active Pharmaceutical Ingredients Basic Information List
Table Mylan Active Pharmaceutical Ingredients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Mylan Active Pharmaceutical Ingredients Sales (K Units) and Growth Rate (2013-2018)
Figure Mylan Active Pharmaceutical Ingredients Sales Market Share in EMEA (2013-2018)
Figure Mylan Active Pharmaceutical Ingredients Revenue Market Share in EMEA (2013-2018)
Table DSM Active Pharmaceutical Ingredients Basic Information List
Table DSM Active Pharmaceutical Ingredients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure DSM Active Pharmaceutical Ingredients Sales (K Units) and Growth Rate (2013-2018)
Figure DSM Active Pharmaceutical Ingredients Sales Market Share in EMEA (2013-2018)
Figure DSM Active Pharmaceutical Ingredients Revenue Market Share in EMEA (2013-2018)
Table Aurobindo Pharma Active Pharmaceutical Ingredients Basic Information List
Table Aurobindo Pharma Active Pharmaceutical Ingredients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Aurobindo Pharma Active Pharmaceutical Ingredients Sales (K Units) and Growth Rate (2013-2018)
Figure Aurobindo Pharma Active Pharmaceutical Ingredients Sales Market Share in EMEA (2013-2018)
Figure Aurobindo Pharma Active Pharmaceutical Ingredients Revenue Market Share in EMEA (2013-2018)
Table Aspen Active Pharmaceutical Ingredients Basic Information List
Table Aspen Active Pharmaceutical Ingredients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Aspen Active Pharmaceutical Ingredients Sales (K Units) and Growth Rate (2013-2018)
Figure Aspen Active Pharmaceutical Ingredients Sales Market Share in EMEA (2013-2018)
Figure Aspen Active Pharmaceutical Ingredients Revenue Market Share in EMEA (2013-2018)
Table Novartis Active Pharmaceutical Ingredients Basic Information List
Table Novartis Active Pharmaceutical Ingredients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novartis Active Pharmaceutical Ingredients Sales (K Units) and Growth Rate (2013-2018)
Figure Novartis Active Pharmaceutical Ingredients Sales Market Share in EMEA (2013-2018)
Figure Novartis Active Pharmaceutical Ingredients Revenue Market Share in EMEA (2013-2018)
Table BASF Active Pharmaceutical Ingredients Basic Information List
Table BASF Active Pharmaceutical Ingredients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure BASF Active Pharmaceutical Ingredients Sales (K Units) and Growth Rate (2013-2018)
Figure BASF Active Pharmaceutical Ingredients Sales Market Share in EMEA (2013-2018)
Figure BASF Active Pharmaceutical Ingredients Revenue Market Share in EMEA (2013-2018)
Table Pfizer Active Pharmaceutical Ingredients Basic Information List
Table Pfizer Active Pharmaceutical Ingredients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pfizer Active Pharmaceutical Ingredients Sales (K Units) and Growth Rate (2013-2018)
Figure Pfizer Active Pharmaceutical Ingredients Sales Market Share in EMEA (2013-2018)
Figure Pfizer Active Pharmaceutical Ingredients Revenue Market Share in EMEA (2013-2018)
Table Huahai Pharmaceutical Active Pharmaceutical Ingredients Basic Information List
Table Huahai Pharmaceutical Active Pharmaceutical Ingredients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Huahai Pharmaceutical Active Pharmaceutical Ingredients Sales (K Units) and Growth Rate (2013-2018)
Figure Huahai Pharmaceutical Active Pharmaceutical Ingredients Sales Market Share in EMEA (2013-2018)
Figure Huahai Pharmaceutical Active Pharmaceutical Ingredients Revenue Market Share in EMEA (2013-2018)
Table Hisun Pharmaceutical Active Pharmaceutical Ingredients Basic Information List
Table Hisun Pharmaceutical Active Pharmaceutical Ingredients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Hisun Pharmaceutical Active Pharmaceutical Ingredients Sales (K Units) and Growth Rate (2013-2018)
Figure Hisun Pharmaceutical Active Pharmaceutical Ingredients Sales Market Share in EMEA (2013-2018)
Figure Hisun Pharmaceutical Active Pharmaceutical Ingredients Revenue Market Share in EMEA (2013-2018)
Table Sun Pharmaceutical Industries Active Pharmaceutical Ingredients Basic Information List
Table Zhejiang Medicine Active Pharmaceutical Ingredients Basic Information List
Table Dr. Reddy's Laboratories Active Pharmaceutical Ingredients Basic Information List
Table Zhejiang NHU Active Pharmaceutical Ingredients Basic Information List
Table Bayer Active Pharmaceutical Ingredients Basic Information List
Table NCPC Active Pharmaceutical Ingredients Basic Information List
Table AbbVie Active Pharmaceutical Ingredients Basic Information List
Table Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients Basic Information List
Table Northeast Pharm Active Pharmaceutical Ingredients Basic Information List
Table Harbin Pharmaceutical Active Pharmaceutical Ingredients Basic Information List
Table LKPC Active Pharmaceutical Ingredients Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Active Pharmaceutical Ingredients
Figure Manufacturing Process Analysis of Active Pharmaceutical Ingredients
Figure Active Pharmaceutical Ingredients Industrial Chain Analysis
Table Raw Materials Sources of Active Pharmaceutical Ingredients Major Manufacturers in 2017
Table Major Buyers of Active Pharmaceutical Ingredients
Table Distributors/Traders List
Figure EMEA Active Pharmaceutical Ingredients Sales (K Units) and Growth Rate Forecast (2018-2025)
Figure EMEA Active Pharmaceutical Ingredients Revenue and Growth Rate Forecast (2018-2025)
Figure EMEA Active Pharmaceutical Ingredients Price (USD/Unit) and Trend Forecast (2018-2025)
Table EMEA Active Pharmaceutical Ingredients Sales (K Units) Forecast by Region (2018-2025)
Figure EMEA Active Pharmaceutical Ingredients Sales Market Share Forecast by Region (2018-2025)
Table EMEA Active Pharmaceutical Ingredients Revenue (Million USD) Forecast by Region (2018-2025)
Figure EMEA Active Pharmaceutical Ingredients Revenue Market Share Forecast by Region (2018-2025)
Table Europe Active Pharmaceutical Ingredients Sales (K Units) Forecast by Countries (2018-2025)
Figure Europe Active Pharmaceutical Ingredients Sales Market Share Forecast by Countries (2018-2025)
Table Europe Active Pharmaceutical Ingredients Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Europe Active Pharmaceutical Ingredients Revenue Market Share Forecast by Countries (2018-2025)
Table Middle East Active Pharmaceutical Ingredients Sales (K Units) Forecast by Countries (2018-2025)
Figure Middle East Active Pharmaceutical Ingredients Sales Market Share Forecast by Countries (2018-2025)
Table Middle East Active Pharmaceutical Ingredients Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Middle East Active Pharmaceutical Ingredients Revenue Market Share Forecast by Countries (2018-2025)
Table Africa Active Pharmaceutical Ingredients Sales (K Units) Forecast by Countries (2018-2025)
Figure Africa Active Pharmaceutical Ingredients Sales Market Share Forecast by Countries (2018-2025)
Table Africa Active Pharmaceutical Ingredients Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Africa Active Pharmaceutical Ingredients Revenue Market Share Forecast by Countries (2018-2025)
Table EMEA Active Pharmaceutical Ingredients Sales (K Units) Forecast by Type (2018-2025)
Figure EMEA Active Pharmaceutical Ingredients Sales Market Share Forecast by Type (2018-2025)
Table EMEA Active Pharmaceutical Ingredients Sales (K Units) Forecast by Application (2018-2025)
Figure EMEA Active Pharmaceutical Ingredients Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources